NEW YORK (GenomeWeb) - WaferGen Biosystems reported after the close of the market Tuesday that its fourth quarter 2015 revenues rose significantly year over year, driven by a 53 percent increase in product revenue, mainly from sales of its existing SmartChip products.

The company said revenues for Q4 2015 were 2.4 million, an increase of 50 percent compared to $1.6 million in the fourth quarter of 2014. The company's product revenues grew 53 percent overall to $2.3 million from about $1.5 million a year ago, while license and royalty revenues were flat at 125,000.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.